Hospira’s Inflectra, EU’s First Biosimilar mAb, Will Challenge Skeptics

Hospira’s Inflectra becomes the first biosimilar monoclonal antibody to be authorized in Europe – but pricing and overcoming doctors’ skepticism looks like the key to real EU success.